ATE195626T1 - Taxol enthaltende zusammensetzung zur verwendung in der organkonservierung und als kardioplegisches mittel - Google Patents

Taxol enthaltende zusammensetzung zur verwendung in der organkonservierung und als kardioplegisches mittel

Info

Publication number
ATE195626T1
ATE195626T1 AT97303064T AT97303064T ATE195626T1 AT E195626 T1 ATE195626 T1 AT E195626T1 AT 97303064 T AT97303064 T AT 97303064T AT 97303064 T AT97303064 T AT 97303064T AT E195626 T1 ATE195626 T1 AT E195626T1
Authority
AT
Austria
Prior art keywords
composition containing
organ preservation
containing taxol
cardioplegic agent
taxol
Prior art date
Application number
AT97303064T
Other languages
English (en)
Inventor
James H Southard
Original Assignee
Wisconsin Alumni Res Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wisconsin Alumni Res Found filed Critical Wisconsin Alumni Res Found
Application granted granted Critical
Publication of ATE195626T1 publication Critical patent/ATE195626T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A01N1/02—Preservation of living parts
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A01N1/02—Preservation of living parts
    • A01N1/0205—Chemical aspects
    • A01N1/021—Preservation or perfusion media, liquids, solids or gases used in the preservation of cells, tissue, organs or bodily fluids
    • A01N1/0221—Freeze-process protecting agents, i.e. substances protecting cells from effects of the physical process, e.g. cryoprotectants, osmolarity regulators like oncotic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Dentistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Epoxy Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT97303064T 1996-05-07 1997-05-06 Taxol enthaltende zusammensetzung zur verwendung in der organkonservierung und als kardioplegisches mittel ATE195626T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/646,055 US5696152A (en) 1996-05-07 1996-05-07 Taxol composition for use as organ preservation and cardioplegic agents

Publications (1)

Publication Number Publication Date
ATE195626T1 true ATE195626T1 (de) 2000-09-15

Family

ID=24591558

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97303064T ATE195626T1 (de) 1996-05-07 1997-05-06 Taxol enthaltende zusammensetzung zur verwendung in der organkonservierung und als kardioplegisches mittel

Country Status (5)

Country Link
US (1) US5696152A (de)
EP (1) EP0806140B1 (de)
JP (1) JP3969785B2 (de)
AT (1) ATE195626T1 (de)
DE (1) DE69702880T2 (de)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6680305B1 (en) * 1993-06-04 2004-01-20 Biotime, Inc. Physiologically acceptable aqueous solutions and methods for their use
US6365385B1 (en) 1999-03-22 2002-04-02 Duke University Methods of culturing and encapsulating pancreatic islet cells
US6303355B1 (en) 1999-03-22 2001-10-16 Duke University Method of culturing, cryopreserving and encapsulating pancreatic islet cells
FR2793651B1 (fr) * 1999-05-18 2003-05-16 Cair L G L Solution aqueuse de conservation de tissus et d'organes
DE10020507A1 (de) * 2000-04-26 2001-11-08 Wolfgang Thasler Lösung zur Konservierung menschlicher Leberzellen, konservierte menschliche Leberzelle, ihre Herstellung und Verwendung
US6696238B2 (en) 2000-07-28 2004-02-24 Christopher J. Murphy Transplant media
GB0028414D0 (en) * 2000-11-22 2001-01-03 Univ Leeds Flush preservation solution
DE10209821A1 (de) 2002-03-06 2003-09-25 Biotechnologie Ges Mittelhesse Kopplung von Proteinen an ein modifiziertes Polysaccharid
DE10209822A1 (de) 2002-03-06 2003-09-25 Biotechnologie Ges Mittelhesse Kopplung niedermolekularer Substanzen an ein modifiziertes Polysaccharid
JP2006516534A (ja) 2002-09-11 2006-07-06 フレセニウス・カビ・ドイッチュラント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング Ｈａｓ化ポリペプチド、特にｈａｓ化エリスロポエチン
EP1475434A1 (de) 2003-05-09 2004-11-10 Oncoscience AG Verfahren zur Lagerung von Tumorzellen
US20050059638A1 (en) * 2003-08-04 2005-03-17 Kelly Michael G. Aryl, heteroaromatic and bicyclic aryl nitrone compounds, prodrugs and pharmaceutical compositions of the same to treat human disorders
WO2005014655A2 (en) 2003-08-08 2005-02-17 Fresenius Kabi Deutschland Gmbh Conjugates of hydroxyalkyl starch and a protein
US20050182060A1 (en) * 2004-02-13 2005-08-18 Kelly Michael G. 2-Substituted and 4-substituted aryl nitrone compounds
EP2336192A1 (de) 2004-03-11 2011-06-22 Fresenius Kabi Deutschland GmbH Hydroxyalkylstärke-Protein-Konjugate, durch reduktive Aminierung hergestellt.
JP2008506750A (ja) * 2004-07-22 2008-03-06 ティオマトリックス・フォルシュンクス・ウント・べラートゥンクス・ゲーエムベーハー チオール基を含む化合物の排出ポンプ抑制剤としての使用
JPWO2006093314A1 (ja) * 2005-03-04 2008-08-07 国立大学法人 東京医科歯科大学 臓器機能維持改善液
US20080161423A1 (en) * 2005-03-04 2008-07-03 Atsushi Kudo Organ Function Maintaining or Amelorating Solution
GB0612877D0 (en) * 2006-06-29 2006-08-09 Univ Edinburgh Organ preservation solution
EP2070950A1 (de) 2007-12-14 2009-06-17 Fresenius Kabi Deutschland GmbH Hydroxyalkylstärkederivate und deren Herstellungsverfahren
US9867368B2 (en) 2011-03-15 2018-01-16 Paragonix Technologies, Inc. System for hypothermic transport of samples
US11178866B2 (en) 2011-03-15 2021-11-23 Paragonix Technologies, Inc. System for hypothermic transport of samples
US9426979B2 (en) 2011-03-15 2016-08-30 Paragonix Technologies, Inc. Apparatus for oxygenation and perfusion of tissue for organ preservation
EP2685814B1 (de) 2011-03-15 2016-08-17 Paragonix Technologies, Inc. Vorrichtung zur sauerstoffanreicherung und perfusion von gewebe zur organkonservierung
US9253976B2 (en) 2011-03-15 2016-02-09 Paragonix Technologies, Inc. Methods and devices for preserving tissues
US8828710B2 (en) 2011-03-15 2014-09-09 Paragonix Technologies, Inc. System for hypothermic transport of samples
US8785116B2 (en) 2012-08-10 2014-07-22 Paragonix Technologies, Inc. Methods for evaluating the suitability of an organ for transplant
US9560846B2 (en) 2012-08-10 2017-02-07 Paragonix Technologies, Inc. System for hypothermic transport of biological samples
US10440947B2 (en) 2013-11-15 2019-10-15 Inserm (Institut National De La Sante Et De La Recherche Medicale) Aqueous solution for preserving an organ and uses during hypothermic ischemia
US11166452B2 (en) 2017-06-07 2021-11-09 Paragonix Technologies, Inc. Apparatus for tissue transport and preservation
US11632951B2 (en) 2020-01-31 2023-04-25 Paragonix Technologies, Inc. Apparatus for tissue transport and preservation

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4879283A (en) * 1985-10-03 1989-11-07 Wisconsin Alumni Research Foundation Solution for the preservation of organs
US4798824A (en) * 1985-10-03 1989-01-17 Wisconsin Alumni Research Foundation Perfusate for the preservation of organs
AU7175591A (en) * 1989-12-21 1991-07-24 Regents Of The University Of California, The Novel and improved technology for preservation of organs for transplantation
US5145771A (en) * 1990-04-12 1992-09-08 The University Of North Carolina At Chapel Hill Rinse solution for organs and tissues
US5407683A (en) * 1990-06-01 1995-04-18 Research Corporation Technologies, Inc. Pharmaceutical solutions and emulsions containing taxol
US5059699A (en) * 1990-08-28 1991-10-22 Virginia Tech Intellectual Properties, Inc. Water soluble derivatives of taxol
US5407793A (en) * 1991-10-18 1995-04-18 University Of Pittsburgh Of The Commonwealth System Of Higher Education An aqueous heart preservation and cardioplegia solution
US5344775A (en) * 1991-11-15 1994-09-06 Escagenetics Corporation Synthesis of taxanes in culture using pseudocalluscells
US5451392A (en) * 1992-03-03 1995-09-19 The Research And Development Institute At Montana State University Production of taxol
DE69329073T2 (de) * 1992-03-23 2001-01-18 Georgetown University Washingt In liposomen verkapseltes taxol und verwendungsverfahren
US5370989A (en) * 1992-04-03 1994-12-06 The Trustees Of Columbia University In The City Of New York Solution for prolonged organ preservation
US5565317A (en) * 1992-06-26 1996-10-15 Torii Pharmaceutical Co., Ltd. Perfusion and storage solution containing sodium lactobionate, sodium dihydrogenphosphate, raffinose, glutathione, allopurinol and nafamostat mesylate
WO1994005282A1 (en) * 1992-09-04 1994-03-17 The Scripps Research Institute Water soluble taxol derivatives
WO1994012172A1 (en) * 1992-12-02 1994-06-09 Thomas Jefferson University Methods of killing protozoal parasites
US5405742A (en) * 1993-07-16 1995-04-11 Cyromedical Sciences, Inc. Solutions for tissue preservation and bloodless surgery and methods using same
WO1995005076A1 (en) * 1993-08-12 1995-02-23 The University Of North Carolina At Chapel Hill Rinse solution for organs and tissues
IL127599A (en) * 1994-01-28 2004-06-01 Upjohn Co Process for preparing isotaxol analogs
US5428039A (en) * 1994-02-20 1995-06-27 The Center For Innovative Technology Method for electively achieving reversible hyperpolarized cardiac arrest

Also Published As

Publication number Publication date
EP0806140B1 (de) 2000-08-23
DE69702880D1 (de) 2000-09-28
JPH1045502A (ja) 1998-02-17
US5696152A (en) 1997-12-09
EP0806140A1 (de) 1997-11-12
JP3969785B2 (ja) 2007-09-05
DE69702880T2 (de) 2001-03-01

Similar Documents

Publication Publication Date Title
ATE195626T1 (de) Taxol enthaltende zusammensetzung zur verwendung in der organkonservierung und als kardioplegisches mittel
ATE248614T1 (de) Gewebeklebstoff auf der basis von fibrinogen und verwendung desselben zur herstellung eines hämostyptikum
NO984619D0 (no) Hemostatisk svamp basert pÕ kollagen
PT799578E (pt) Preparacao combinada contendo germes enriquecidos com electrolitos
DE69429536T2 (de) Analgetisches Mittel und dessen Verwendung
ATE295147T1 (de) Oxidationsfärbungszusammensetzung für keratinische fasern und färbungsverfahren mit derselben
SE9504505D0 (sv) Förvaringslösning
DE3780940D1 (de) Verwendung von ketonderivaten zur behandlung von depressionen.
ITMI931994A0 (it) Soluzione di perfusione, conservazione e riperfusione d'organi
DK0775439T3 (da) Sammensætninger indeholdende dialkyl(C1-C6)-ketonperoxid til konservering af organiske væv og påføring af sammensætningerne til konservering og anatomisk præparering af organiske væv af dyrisk eller menneskelig oprindelse
DE69803383D1 (de) Selektive inhibitoren des faktors x, eine azepinonstruktur enthaltend
FR2832314B1 (fr) Sonde medicale intraluminale
DE59900067D1 (de) Verwendung eines Mittels zur Haarbehandlung
BR9705279A (pt) Utilização de um organossiloxano e processo de tratamento cosmético.
ES2153856T3 (es) Agente conservante para organos.
FR2723818B1 (fr) Composition de perfusion pour ameliorer la conservation d'organes vivants
ES2190918T3 (es) Agente antiseptico/antifungico y composicion de linimento endermico que lo contiene.
DE59003312D1 (de) Verwendung von Diphenyletherderivaten zur Desikkation und Abszission von Pflanzenorganen.
ATE309807T1 (de) Zusammensetzung zur behandlung von atherosklerose,welche ein statin und ex-vivo behandeltes blut enthält
DE60011107D1 (de) Sterilisationsmittel und -verfahren
AU8131794A (en) Composition for tissue and organ transplantation preservation
ATE292970T1 (de) Topische zusammensetzung enthaltend brucin und ihre verwendung zur behandlung von hautschäden
DE60007991D1 (de) Verwendung des proteins uk 114 zur verhinderung der abstossung eines transplantierten organs
DE59407576D1 (de) Verwendung von Etofibrat und pharmazeutische Zusammensetzungen, enthaltend Etofibrat, zur Behandlung der diabetischen Angio- und Retinopathie
UA10155C2 (uk) Розчин для консервування живих органів

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee